ReviewFrontiers in pharmacology2021

Research Progress on Strategies that can Enhance the Therapeutic Benefits of Mesenchymal Stromal Cells in Respiratory Diseases With a Specific Focus on Acute Respiratory Distress Syndrome and Other Inflammatory Lung Diseases.

Sara Rolandsson Enes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.